Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics
Completed · Phase 1
Conditions studied: Type 1 Diabetes Mellitus
In brief
Type 1 diabetes is caused by an autoimmune destruction of the insulin producing cells of the pancreas. The investigators have discovered the specific autoimmune cells responsible for destroying the insulin-producing cells in an animal model of type 1 diabetes, and the means of destroying those cells.
Key facts
- Study ID
- NCT00607230
- Run by
- Massachusetts General Hospital
- People needed
- 25
- Starts
- 2007-11-01
- Expected to finish
- 2011-02-01
- Last updated by the study team
- 2013-11-05
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Diabetes Research Center at Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.